Dalton Bioanalytics
Digitizing the biochemical composition of blood for the future of human health
Los Angeles · Founded 2019 · $250K raised
- Headquarters
- Los Angeles
- Employees
- 11–50
- Founded
- 2019
- Business Model
- B2B
- Website
- daltonbioanalytics.com
- Total Funding
- $250K
- Last Round
- $250K SeedAug 2019
- Rounds
- 1
About
Dalton Bioanalytics is at the forefront of the multiomics revolution, providing advanced CRO services for proteomics, metabolomics, lipidomics, and exposomics. Their proprietary Omni-MS® platform enables the analysis of over 1,000 biochemicals in a single sample, digitizing the complete biochemical composition of biofluid samples to accelerate drug discovery and biomarker research.
Summary
Dalton Bioanalytics is a company based in Los Angeles, founded in 2019. It has raised $250K in total across 1 round, most recently a $250K Seed round in Aug 2019. Investors include IndieBio and SOSV.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Aug 2019
